RASA2_HUMAN - dbPTM
RASA2_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID RASA2_HUMAN
UniProt AC Q15283
Protein Name Ras GTPase-activating protein 2
Gene Name RASA2
Organism Homo sapiens (Human).
Sequence Length 850
Subcellular Localization Cytoplasm. Cytoplasm, perinuclear region.
Protein Description Inhibitory regulator of the Ras-cyclic AMP pathway. Binds inositol tetrakisphosphate (IP4)..
Protein Sequence MAAAAPAAAAASSEAPAASATAEPEAGDQDSREVRVLQSLRGKICEAKNLLPYLGPHKMRDCFCTINLDQEEVYRTQVVEKSLSPFFSEEFYFEIPRTFQYLSFYVYDKNVLQRDLRIGKVAIKKEDLCNHSGKETWFSLQPVDSNSEVQGKVHLELKLNELITENGTVCQQLVVHIKACHGLPLINGQSCDPYATVSLVGPSRNDQKKTKVKKKTSNPQFNEIFYFEVTRSSSYTRKSQFQVEEEDIEKLEIRIDLWNNGNLVQDVFLGEIKVPVNVLRTDSSHQAWYLLQPRDNGNKSSKTDDLGSLRLNICYTEDYVLPSEYYGPLKTLLLKSPDVQPISASAAYILSEICRDKNDAVLPLVRLLLHHDKLVPFATAVAELDLKDTQDANTIFRGNSLATRCLDEMMKIVGGHYLKVTLKPILDEICDSSKSCEIDPIKLKEGDNVENNKENLRYYVDKLFNTIVKSSMSCPTVMCDIFYSLRQMATQRFPNDPHVQYSAVSSFVFLRFFAVAVVSPHTFHLRPHHPDAQTIRTLTLISKTIQTLGSWGSLSKSKSSFKETFMCEFFKMFQEEGYIIAVKKFLDEISSTETKESSGTSEPVHLKEGEMYKRAQGRTRIGKKNFKKRWFCLTSRELTYHKQPGSKDAIYTIPVKNILAVEKLEESSFNKKNMFQVIHTEKPLYVQANNCVEANEWIDVLCRVSRCNQNRLSFYHPSVYLNGNWLCCQETGENTLGCKPCTAGVPADIQIDIDEDRETERIYSLFTLSLLKLQKMEEACGTIAVYQGPQKEPDDYSNFVIEDSVTTFKTIQQIKSIIEKLDEPHEKYRKKRSSSAKYGSKENPIVGKAS
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Acetylation------MAAAAPAAA
------CCCHHHHHH
13.0522223895
48SumoylationRGKICEAKNLLPYLG
CCCHHHHHCCHHHCC
26.32-
58AcetylationLPYLGPHKMRDCFCT
HHHCCCCCCCCEEEE
38.4725953088
124AcetylationRIGKVAIKKEDLCNH
CCCCEEEEHHHHCCC
40.1370509
134UbiquitinationDLCNHSGKETWFSLQ
HHCCCCCCCCEEEEE
55.7929967540
208AcetylationGPSRNDQKKTKVKKK
CCCCCHHHCCCCCCC
66.3319608861
209AcetylationPSRNDQKKTKVKKKT
CCCCHHHCCCCCCCC
48.2019608861
211AcetylationRNDQKKTKVKKKTSN
CCHHHCCCCCCCCCC
62.0219608861
213AcetylationDQKKTKVKKKTSNPQ
HHHCCCCCCCCCCCC
50.5419608861
214AcetylationQKKTKVKKKTSNPQF
HHCCCCCCCCCCCCC
65.36133589
216PhosphorylationKTKVKKKTSNPQFNE
CCCCCCCCCCCCCCE
42.4928464451
217PhosphorylationTKVKKKTSNPQFNEI
CCCCCCCCCCCCCEE
56.2328464451
226PhosphorylationPQFNEIFYFEVTRSS
CCCCEEEEEEEECCC
12.4227642862
233PhosphorylationYFEVTRSSSYTRKSQ
EEEEECCCCCCCCCC
24.8726074081
234PhosphorylationFEVTRSSSYTRKSQF
EEEECCCCCCCCCCE
31.6026074081
235PhosphorylationEVTRSSSYTRKSQFQ
EEECCCCCCCCCCEE
16.7126074081
239PhosphorylationSSSYTRKSQFQVEEE
CCCCCCCCCEEECHH
32.7029514088
302UbiquitinationDNGNKSSKTDDLGSL
CCCCCCCCCCCCCCE
64.1624816145
305UbiquitinationNKSSKTDDLGSLRLN
CCCCCCCCCCCEEEE
59.1524816145
308PhosphorylationSKTDDLGSLRLNICY
CCCCCCCCEEEEEEE
20.0124719451
324UbiquitinationEDYVLPSEYYGPLKT
CCCCCCHHHHCCHHH
40.6124816145
357UbiquitinationLSEICRDKNDAVLPL
HHHHCCCCCCCHHHH
37.0624816145
360UbiquitinationICRDKNDAVLPLVRL
HCCCCCCCHHHHHHH
17.7224816145
379UbiquitinationDKLVPFATAVAELDL
CCHHCHHHEEEECCC
23.2624816145
419UbiquitinationIVGGHYLKVTLKPIL
HHCCCEEEEEEHHHH
26.4732015554
423UbiquitinationHYLKVTLKPILDEIC
CEEEEEEHHHHHHHH
22.2032015554
440UbiquitinationSKSCEIDPIKLKEGD
CCCCCCCCCCCCCCC
31.1324816145
442UbiquitinationSCEIDPIKLKEGDNV
CCCCCCCCCCCCCCC
59.9229967540
462UbiquitinationNLRYYVDKLFNTIVK
HHHHHHHHHHHHHHH
44.96-
484PhosphorylationVMCDIFYSLRQMATQ
HHHHHHHHHHHHHHH
13.3124719451
501PhosphorylationPNDPHVQYSAVSSFV
CCCCCCCHHHHHHHH
9.4827251275
502PhosphorylationNDPHVQYSAVSSFVF
CCCCCCHHHHHHHHH
12.7127251275
505PhosphorylationHVQYSAVSSFVFLRF
CCCHHHHHHHHHHHH
20.1327251275
506PhosphorylationVQYSAVSSFVFLRFF
CCHHHHHHHHHHHHH
20.8727251275
537PhosphorylationPDAQTIRTLTLISKT
CCHHHHHHHHHHHHH
21.9030576142
542PhosphorylationIRTLTLISKTIQTLG
HHHHHHHHHHHHHHH
27.1930576142
544PhosphorylationTLTLISKTIQTLGSW
HHHHHHHHHHHHHCC
16.13-
550PhosphorylationKTIQTLGSWGSLSKS
HHHHHHHCCCCCCCC
31.2328348404
553PhosphorylationQTLGSWGSLSKSKSS
HHHHCCCCCCCCHHH
24.1825159151
555PhosphorylationLGSWGSLSKSKSSFK
HHCCCCCCCCHHHHH
36.2628348404
557PhosphorylationSWGSLSKSKSSFKET
CCCCCCCCHHHHHHH
34.1028450419
559PhosphorylationGSLSKSKSSFKETFM
CCCCCCHHHHHHHHH
48.3628450419
560PhosphorylationSLSKSKSSFKETFMC
CCCCCHHHHHHHHHH
44.0428464451
564PhosphorylationSKSSFKETFMCEFFK
CHHHHHHHHHHHHHH
19.7728450419
584UbiquitinationGYIIAVKKFLDEISS
CEEEEEHHHHHHHCC
44.5629967540
591PhosphorylationKFLDEISSTETKESS
HHHHHHCCCCCCCCC
35.6024719451
597PhosphorylationSSTETKESSGTSEPV
CCCCCCCCCCCCCCE
35.3129255136
598PhosphorylationSTETKESSGTSEPVH
CCCCCCCCCCCCCEE
47.3729255136
600PhosphorylationETKESSGTSEPVHLK
CCCCCCCCCCCEECC
31.6829255136
601PhosphorylationTKESSGTSEPVHLKE
CCCCCCCCCCEECCC
43.3528348404
607UbiquitinationTSEPVHLKEGEMYKR
CCCCEECCCCHHHHH
49.1229967540
612PhosphorylationHLKEGEMYKRAQGRT
ECCCCHHHHHCCCCC
7.94-
651PhosphorylationPGSKDAIYTIPVKNI
CCCCCCEEEEEHHHE
16.8227642862
656UbiquitinationAIYTIPVKNILAVEK
CEEEEEHHHEEEEEE
34.4429967540
759PhosphorylationDIDEDRETERIYSLF
ECCCCCCHHHHHHHH
32.12-
769PhosphorylationIYSLFTLSLLKLQKM
HHHHHHHHHHHHHHH
5.7120860994
782PhosphorylationKMEEACGTIAVYQGP
HHHHHHCEEEEEECC
1.1622817900
786PhosphorylationACGTIAVYQGPQKEP
HHCEEEEEECCCCCC
50.9522817900
796PhosphorylationPQKEPDDYSNFVIED
CCCCCCCCCCCEEEC
30.6822817900
808UbiquitinationIEDSVTTFKTIQQIK
EECCCCCHHHHHHHH
42.5029967540
809UbiquitinationEDSVTTFKTIQQIKS
ECCCCCHHHHHHHHH
21.5929967540
812UbiquitinationVTTFKTIQQIKSIIE
CCCHHHHHHHHHHHH
41.0229967540
814UbiquitinationTFKTIQQIKSIIEKL
CHHHHHHHHHHHHHC
31.1229967540
815UbiquitinationFKTIQQIKSIIEKLD
HHHHHHHHHHHHHCC
30.3529967540
816PhosphorylationKTIQQIKSIIEKLDE
HHHHHHHHHHHHCCC
3.9122210691
818UbiquitinationIQQIKSIIEKLDEPH
HHHHHHHHHHCCCHH
45.9929967540
833PhosphorylationEKYRKKRSSSAKYGS
HHHHHHHCCCCCCCC
38.0528634298
834PhosphorylationKYRKKRSSSAKYGSK
HHHHHHCCCCCCCCC
29.9928634298
835PhosphorylationYRKKRSSSAKYGSKE
HHHHHCCCCCCCCCC
15.8428634298
838PhosphorylationKRSSSAKYGSKENPI
HHCCCCCCCCCCCCC
31.3829759185
840PhosphorylationSSSAKYGSKENPIVG
CCCCCCCCCCCCCCC
58.0928122231
847UbiquitinationSKENPIVGKAS----
CCCCCCCCCCC----
34.2624816145
848UbiquitinationKENPIVGKAS-----
CCCCCCCCCC-----
17.9724816145
851UbiquitinationPIVGKAS--------
CCCCCCC--------
24816145
869Ubiquitination--------------------------
--------------------------
24816145
870Ubiquitination---------------------------
---------------------------
24816145

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of RASA2_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of RASA2_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of RASA2_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions

Oops, there are no PPI records of RASA2_HUMAN !!

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of RASA2_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY.
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-208; LYS-209; LYS-211 ANDLYS-213, AND MASS SPECTROMETRY.

TOP